04/10/2024
3:05 PM | Prelude Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
4:22 PM | Prelude Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/15/2024
3:22 PM | Prelude Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
12:34 PM | Prelude Therapeutics (Subject)
UBS ASSET MANAGEMENT AMERICAS INC (Filed by)
| Form SC 13G/A | |
02/12/2024
4:30 PM | Flynn James E (Filed by)
Prelude Therapeutics (Subject)
| Form SC 13G/A | |
02/12/2024
3:26 PM | Prelude Therapeutics (Subject)
Vaddi Krishna (Filed by)
| Form SC 13G/A | |
01/10/2024
7:53 AM | FMR LLC (Filed by)
Prelude Therapeutics (Subject)
| Form SC 13G/A | |
|
01/08/2024
4:00 PM | Huang Jane (Reporting)
Prelude Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
3:35 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Prelude Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
8:17 AM | Prelude Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
7:30 AM | Flynn James E (Filed by)
Prelude Therapeutics (Subject)
| Form SC 13G | |
11/01/2023
3:37 PM | Prelude Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2023
3:23 PM | Prelude Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/06/2023
8:07 AM | Huang Jane (Reporting)
Prelude Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
7:10 AM | Prelude Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
7:14 AM | Prelude Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/06/2023
3:35 PM | Huang Jane (Reporting)
Prelude Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:47 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Prelude Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:11 PM | Babler Martin (Reporting)
Prelude Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:12 PM | Bonita David P (Reporting)
Prelude Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:13 PM | Dier Mardi (Reporting)
Prelude Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:14 PM | FRIEDMAN PAUL A (Reporting)
Prelude Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:16 PM | Prelude Therapeutics (Issuer)
Sandor Victor (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:05 PM | Prelude Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/01/2023
3:25 PM | Prelude Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/26/2023
3:20 PM | Prelude Therapeutics (Issuer)
Vaddi Krishna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
4:07 PM | Bonita David P (Reporting)
Prelude Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
4:09 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
ORBIMED CAPITAL LLC (Reporting)
Prelude Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
3:31 PM | BAKER BROS. ADVISORS LP (Filed by)
Prelude Therapeutics (Subject)
| Form SC 13D/A | |
05/18/2023
5:05 AM | Prelude Therapeutics (Subject)
| Form FWP | |
05/08/2023
7:06 AM | Prelude Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2023
7:11 AM | Prelude Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/28/2023
8:41 AM | Prelude Therapeutics (Filer)
| Form DEFA14A | |
04/28/2023
8:46 AM | Prelude Therapeutics (Filer)
| Form ARS | |
04/28/2023
7:46 AM | Prelude Therapeutics (Filer)
| Form DEF 14A | |
